AORT Artivion Inc
Price (delayed)
$24.67
Market cap
$1.04B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.32
Enterprise value
$1.35B
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins
Highlights
Artivion's EPS has surged by 57% YoY
The net income has soared by 56% YoY
AORT's quick ratio has surged by 138% since the previous quarter but it is down by 9% year-on-year
Artivion's equity has decreased by 9% QoQ
Key stats
What are the main financial stats of AORT
Market
Valuations
Earnings
Shares outstanding
42.05M
Market cap
$1.04B
Enterprise value
$1.35B
Price to earnings (P/E)
N/A
Price to book (P/B)
3.74
Price to sales (P/S)
2.65
EV/EBIT
50.3
EV/EBITDA
24.09
EV/Sales
3.46
Revenue
$388.54M
Gross profit
$248.78M
Operating income
$38.87M
Net income
-$13.36M
EBIT
$26.76M
EBITDA
$55.88M
Free cash flow
$11.05M
Per share
Balance sheet
Liquidity
EPS
-$0.32
EPS diluted
-$0.32
Free cash flow per share
$0.27
Book value per share
$6.59
Revenue per share
$9.32
TBVPS
$9.4
Total assets
$789.1M
Total liabilities
$512.9M
Debt
$362.26M
Equity
$276.2M
Working capital
$223.26M
Debt to equity
1.31
Current ratio
4.34
Quick ratio
2.09
Net debt/EBITDA
5.53
Margins
Efficiency
Dividend
EBITDA margin
14.4%
Gross margin
64%
Net margin
-3.4%
Operating margin
10%
Return on assets
-1.7%
Return on equity
-4.6%
Return on invested capital
4.4%
Return on capital employed
3.7%
Return on sales
6.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AORT stock price
How has the Artivion stock price performed over time
Intraday
0.37%
1 week
0%
1 month
-2.91%
1 year
16.42%
YTD
-13.71%
QTD
0.37%
Financial performance
How have Artivion's revenue and profit performed over time
Revenue
$388.54M
Gross profit
$248.78M
Operating income
$38.87M
Net income
-$13.36M
Gross margin
64%
Net margin
-3.4%
AORT's net margin has soared by 61% year-on-year
The net income has soared by 56% YoY
The company's revenue rose by 10% YoY
Artivion's gross profit has increased by 9% YoY
Growth
What is Artivion's growth rate over time
Valuation
What is Artivion stock price valuation
P/E
N/A
P/B
3.74
P/S
2.65
EV/EBIT
50.3
EV/EBITDA
24.09
EV/Sales
3.46
Artivion's EPS has surged by 57% YoY
The stock's price to book (P/B) is 33% more than its 5-year quarterly average of 2.8 and 3.6% more than its last 4 quarters average of 3.6
Artivion's equity has decreased by 9% QoQ
The company's revenue rose by 10% YoY
The price to sales (P/S) is 6% lower than the last 4 quarters average of 2.8
Efficiency
How efficient is Artivion business performance
AORT's ROE has soared by 58% YoY
AORT's return on assets has surged by 58% year-on-year
The ROIC is down by 32% QoQ
Artivion's return on sales has decreased by 32% QoQ
Dividends
What is AORT's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history
Special dividends are included in TTM DPS and yield
Financial health
How did Artivion financials performed over time
The total assets is 54% greater than the total liabilities
AORT's quick ratio has surged by 138% since the previous quarter but it is down by 9% year-on-year
AORT's current ratio has soared by 131% since the previous quarter but it is down by 11% year-on-year
AORT's debt is 31% greater than its equity
The debt to equity has grown by 10% from the previous quarter and by 3.1% YoY
Artivion's equity has decreased by 9% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.